Article

jdsupra.com on 2022-04-25 18:54

FDA Publishes Final Guidance for Industry on Drug Products, Including Biological Products, that Contain Nanomaterials

The U.S. Food and Drug Administration (FDA) announced on April 22, 2022, the availability of a final guidance for industry entitled “Drug Products, ...

Reg

Related news

FDA Updates Draft Guidance on Promotional Labeling and Advertising Considerations for Biological Reference Products and Biosimilars jdsupra.com
Reg
FDA Final Guidance on Nonproprietary Names of Biological Products jdsupra.com
Purple Book Database Of Biological Products Updated By FDA jdsupra.com
FDA Upgrades Its Database Of Licensed Biological Products jdsupra.com
California , United States , Switzerland
FDA Requests Comments On Its Licensed Biological Products Database jdsupra.com
California , United States , Switzerland
FDA Publishes White Paper on Artificial Intelligence & Medical Products jdsupra.com
Reg , Guiding
FDA Publishes Consumer Update on Cannabis Products, Including CBD jdsupra.com
California , United States , Switzerland
Summary of FDA Guidance on the Nonproprietary Naming of Biological Products jdsupra.com
Guiding , United States
FDA Releases Draft Guidance on Promotion of Biological Reference and Biosimilar Products jdsupra.com
California , United States , Switzerland
GSA Publishes RFI Regarding PFAS in Products jdsupra.com
Reg
FDA Issues Draft Guidance on Decentralized Clinical Trials for Drugs, Biological Products and Devices jdsupra.com
FDA Issues Draft Guidance and Proposed Rule on the Nonproprietary Naming of Biological Products jdsupra.com
United States
Lamar Odom's 'herbal Viagra': FDA warns 'natural' sex enhancement products contain unlisted ingredients al.com
FDA Publishes Draft Ethical Consideration Guidance to Protect Children Participants in Clinical Trials of Medical Products jdsupra.com
FDA Publishes Final Rule on Regulation of Lab-Developed Tests jdsupra.com
Reg
FDA Publishes “Public List” of Deemed Tobacco Products, But Leaves Critical Flaws in Apprising Stakeholders of Lawfully-Marketed Products jdsupra.com
United States
New Government Action Aims to Increase Competition among Biological Products: FDA and FTC Step Up Industry Pressure jdsupra.com
California , United States , Switzerland
It’s Starting to Register: FDA Draft Guidance Addresses Use of Registries to Support Regulatory Decision-Making for Drugs & Biological Products jdsupra.com
Cures
2021 Year in Review: OPDP Enforcement Actions Involving Prescription and Biological Products jdsupra.com
Reg
French NGO Claims Certain Everyday Products Contain Unlabeled Nanomaterials jdsupra.com
France